Havens Advisors’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-46,000
Closed -$2.11M 42
2015
Q1
$2.11M Buy
+46,000
New +$1.38M 1.69% 19

Havens Advisors's HPTX Position: Q2 2015 in Review

Havens Advisors sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 46,000 shares — an estimated $2.11M sold.

Havens Advisors first reported a position in HPTX in Q1 2015 and held it in 1 quarter. The position peaked at $2.11M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Havens Advisors reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Havens Advisors sold 46,000 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $2.11M.
  • Havens Advisors first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Havens Advisors's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $2.11M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Havens Advisors's 13F filing for Q2 2015, filed 6 Aug 2015.